Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 2.9B | 2.7B | 2.8B | 3.0B |
Cost of revenue | 1.5B | 1.4B | 1.4B | 1.5B |
Gross profit | 1.4B | 1.3B | 1.3B | 1.5B |
Operating expense | ||||
Research & development | 59M | 55M | 61M | 53M |
Selling general and admin | 303M | 293M | 268M | 286M |
Other operating expenses | 75M | 68M | 69M | 78M |
Operating income | 603M | 519M | 610M | 734M |
Non operating interest income | ||||
Income | 57M | 67M | 80M | 71M |
Expense | 180M | 179M | 186M | 182M |
Other income expense | -19M | -4M | -8M | -23M |
Pretax income | 461M | 403M | 496M | 600M |
Tax provision | 69M | 50M | 72M | 17M |
Net income | 392M | 353M | 424M | 583M |
Basic EPS | — | 0.4 | 0.5 | 0.7 |
Diluted EPS | — | 0.4 | 0.5 | 0.7 |
Basic average shares | — | 730M | 740M | 750M |
Diluted average shares | — | 731M | 741M | 752M |
EBITDA | 1.0B | 936M | 1.0B | 1.1B |
Net income from continuing op. | 392M | 353M | 424M | 583M |
Minority interests | -68M | -78M | -71M | -89M |
Preferred stock dividends | — | — | — | — |